Company research / NRIX
Nurix Therapeutics, Inc. (NRIX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Nov 30
For the year ended 2025-11-30, Nurix Therapeutics, Inc. reported revenue of $83.98M. Revenue grew 54.0% from the prior annual period.
Key ratios (year ended 2025-11-30)
-340.2%
Operating margin
-314.9%
Net margin
-49.1%
Return on year-end equity
54.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.